Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02978443
Title A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Georgetown University
Indications

mucosal melanoma

acral lentiginous melanoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Lombardi Comprehensive Cancer Center Washington District of Columbia 20007 United States Details
Washington Cancer Institute at MedStar Washington Hospital Center Washington District of Columbia 20010 United States Details
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
John Theurer Cacner Center at Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field